Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a small update to the site's underlying system.
    Difference
    0.1%
    Check dated 2026-09-01T19:33:48.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4; this appears to be a software version update with no visible changes to study details or content.
    Difference
    0.1%
    Check dated 2026-08-11T16:35:41.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.3 to v3.6.4, indicating a new content release.
    Difference
    0.1%
    Check dated 2026-07-28T10:30:51.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    New entries were added to the Study Record Dates for 2026-07-16, 2027-04-08, 2026-06-25, and 2026-06, and older dates 2025-07-20, 2026-05-04, 2025-07-09, and 2025-07 were removed. These changes update the historical timeline of the study record on the page.
    Difference
    0.3%
    Check dated 2026-07-21T11:14:46.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3, indicating a small update to the page’s versioning or metadata rather than any changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-07T02:56:52.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a software update to the page rendering. This likely reflects backend/frontend improvements and does not modify the study information.
    Difference
    0.1%
    Check dated 2026-06-29T17:42:31.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.